| 000 | 01357 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511202914.0 | ||
| 264 | 0 | _c19920117 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0169-6009 | ||
| 024 | 7 |
_a10.1016/0169-6009(91)90111-c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdami, S | |
| 245 | 0 | 0 |
_aThe prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. _h[electronic resource] |
| 260 |
_bBone and mineral _cOct 1991 |
||
| 300 |
_a73-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNandrolone _xanalogs & derivatives |
| 650 | 0 | 4 | _aNandrolone Decanoate |
| 650 | 0 | 4 |
_aOsteocalcin _xblood |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aFossaluzza, V | |
| 700 | 1 | _aRossini, M | |
| 700 | 1 | _aBertoldo, F | |
| 700 | 1 | _aGatti, D | |
| 700 | 1 | _aZamberlan, N | |
| 700 | 1 | _aLo Cascio, V | |
| 773 | 0 |
_tBone and mineral _gvol. 15 _gno. 1 _gp. 73-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0169-6009(91)90111-c _zAvailable from publisher's website |
| 999 |
_c1753964 _d1753964 |
||